Amy Gravely
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amy Gravely has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Anders Westanmo
Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota
2 shared publications Dimitri M. Drekonja
Minneapolis Veterans Affairs Health Care System, and University of Minnesota, Minneapolis, Minnesota, USA
2 shared publicationsSiamak Noorbaloochi
VA HSR&D Center for Chronic Disease Outcomes Research (CCDOR), Minneapolis VA Health Care System, Minneapolis, Minnesota
2 shared publications- Aaron S. DeVries
Minneapolis VA Medical Center
1 shared publication - Aasma Shaukat
Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
1 shared publication Agnes C. Jensen
Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System, One Veterans Drive (152), Minneapolis, MN 55417, USA
1 shared publication
Latest Publications
- 23 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (9) , 1363-1365
Outpatient Antibiotic Prescribing for Uncomplicated Diverticulitis in Veterans Affairs Facilities: A Retrospective Cohort Study
- 23 June 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (9) , 1363-1365
Outpatient Antibiotic Prescribing for Uncomplicated Diverticulitis in Veterans Affairs Facilities: A Retrospective Cohort Study
- Open Access
- 21 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0337185
Randomized crossover trial of hand and hydrostatic casting for custom lower limb prosthetic sockets: Assessing socket comfort and fabrication time
The aim of this study was to compare diagnostic sockets made by hand casting and standing hydrostatic pressure casting in persons with lower limb amputation. This multi-site, single-masked, randomized crossover trial (ClinicalTrials.gov NCT04141748) involved a prosthetist at each site taking one cast by hand (H) and another using hydrostatic casting (S). The process of casting, rectifying and modifying a diagnostic socket was timed in minutes. Socket comfort score (SCS) was assessed during static fitting of the diagnostic socket before (initial) and after (final) any modifications were made by the prosthetist. Difference scores for comfort and timing were calculated for each pair of casts within prosthetist. Bootstrapping methods were used to determine if the mean difference scores were significantly different from zero. Eighty participants with unilateral lower limb amputation were enrolled, with 75 completing the study. The initial SCS was significantly better in the transfemoral amputation group (TFA, n = 24) for the socket made from hand casting (H: 7.1 ± 1.9, S: 6.5 ± 2.2; p = 0.043). The final SCS was significantly better in the transtibial amputation group (TTA, n = 51) for the socket made from hydrostatic casting (H: 7.5 ± 2.0, S: 8.1 ± 1.3; p = 0.025). Total fabrication time for hydrostatic casting was significantly greater than hand casting (H: 42.1 ± 15.6, S: 48.0 ± 10.7; p = 0.001). It took significantly more time to cast (H: 10.6 ± 5.5, S: 23.7 ± 6.1; p < 0.0001) and significantly less time to rectify with hydrostatic casting (H: 23.4 ± 11.1, S: 16.6 ± 17.2; p < 0.0001). There was no difference between casting approaches for time to modify the diagnostic socket (H: 8.1 ± 7.5, S: 7.7 ± 6.6; p = 0.641). In individuals with both TTA and TFA results suggest that hydrostatic casting took more total time than hand casting to fabricate a diagnostic socket. While hand casting resulted in a significantly more comfortable socket initially for the TFA group, hydrostatic casting led to a more comfortable final socket for the TTA group.
- 21 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0337185
Open AccessRandomized crossover trial of hand and hydrostatic casting for custom lower limb prosthetic sockets: Assessing socket comfort and fabrication time
The aim of this study was to compare diagnostic sockets made by hand casting and standing hydrostatic pressure casting in persons with lower limb amputation. This multi-site, single-masked, randomized crossover trial (ClinicalTrials.gov NCT04141748) involved a prosthetist at each site taking one cast by hand (H) and another using hydrostatic casting (S). The process of casting, rectifying and modifying a diagnostic socket was timed in minutes. Socket comfort score (SCS) was assessed during static fitting of the diagnostic socket before (initial) and after (final) any modifications were made by the prosthetist. Difference scores for comfort and timing were calculated for each pair of casts within prosthetist. Bootstrapping methods were used to determine if the mean difference scores were significantly different from zero. Eighty participants with unilateral lower limb amputation were enrolled, with 75 completing the study. The initial SCS was significantly better in the transfemoral amputation group (TFA, n = 24) for the socket made from hand casting (H: 7.1 ± 1.9, S: 6.5 ± 2.2; p = 0.043). The final SCS was significantly better in the transtibial amputation group (TTA, n = 51) for the socket made from hydrostatic casting (H: 7.5 ± 2.0, S: 8.1 ± 1.3; p = 0.025). Total fabrication time for hydrostatic casting was significantly greater than hand casting (H: 42.1 ± 15.6, S: 48.0 ± 10.7; p = 0.001). It took significantly more time to cast (H: 10.6 ± 5.5, S: 23.7 ± 6.1; p < 0.0001) and significantly less time to rectify with hydrostatic casting (H: 23.4 ± 11.1, S: 16.6 ± 17.2; p < 0.0001). There was no difference between casting approaches for time to modify the diagnostic socket (H: 8.1 ± 7.5, S: 7.7 ± 6.6; p = 0.641). In individuals with both TTA and TFA results suggest that hydrostatic casting took more total time than hand casting to fabricate a diagnostic socket. While hand casting resulted in a significantly more comfortable socket initially for the TFA group, hydrostatic casting led to a more comfortable final socket for the TTA group.
- 7 July 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (3) , 776-784
Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Positive Individuals: Prevalence, Predictors, and Root Cause Analysis in a Nationwide Cohort
INTRODUCTION: Postcolonoscopy colorectal cancer (PCCRC) represents an important real-world colonoscopy quality indicator. Using a national database, we evaluated predictors of PCCRC in fecal immunochemical test (FIT)-positive individuals, determined the PCCRC 3-year (PCCRC-3y) rate, and performed a root cause analysis (RCA). METHODS: This retrospective cohort study evaluated FIT-positive patients who underwent colonoscopy from January 2015 to July 2022. Data were collected from the Veterans Affairs national database. PCCRC was defined as CRC detected ≥6 months after colonoscopy. CRC was identified using Systematized Nomenclature of Medicine codes and the Veterans Affairs Cancer Registry. The World Endoscopy Organization methodology was used to perform the RCA and calculate the PCCRC-3y rate. RESULTS: We identified 132 PCCRCs among 52,167 FIT-positive individuals. The PCCRC-3y rate was 6.4% (95% confidence interval [CI] 5.0%–7.7%). PCCRC locations were proximal colon (43.2%), distal colon (34.8%), and rectum (22%). Root causes were likely new CRC (17.4%), missed lesions with adequate (31.2%) or inadequate (9.8%) examination, incomplete polyp resection (22%), and detected but unresected lesions (19.7%). 16.7% of patients with PCCRC had poor bowel preparation on index colonoscopy. The cecal intubation rate was 88.6%, and rectal retroflexion rate was 84.5%. In 14.4% of cases, recommended surveillance intervals did not adhere to established guidelines. Independent predictors of PCCRC were ages 70–79 years (hazard ratio [HR] 7.86; 95% CI 1.08–57.39), age ≥80 years (HR 10.18; 95% CI 1.06–97.98), tubulovillous adenoma (HR 3.98; 95% CI 2.52–6.29), and adenoma with high-grade dysplasia (HR 10.15; 95% CI 5.91–17.42). DISCUSSION: Among FIT-positive individuals, the PCCRC-3y rate was 6.4%, with missed lesions and incomplete resection as key contributors. These findings provide useful information on quality metrics in FIT-based CRC-screening programs.
- 7 July 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (3) , 776-784
Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Positive Individuals: Prevalence, Predictors, and Root Cause Analysis in a Nationwide Cohort
INTRODUCTION: Postcolonoscopy colorectal cancer (PCCRC) represents an important real-world colonoscopy quality indicator. Using a national database, we evaluated predictors of PCCRC in fecal immunochemical test (FIT)-positive individuals, determined the PCCRC 3-year (PCCRC-3y) rate, and performed a root cause analysis (RCA). METHODS: This retrospective cohort study evaluated FIT-positive patients who underwent colonoscopy from January 2015 to July 2022. Data were collected from the Veterans Affairs national database. PCCRC was defined as CRC detected ≥6 months after colonoscopy. CRC was identified using Systematized Nomenclature of Medicine codes and the Veterans Affairs Cancer Registry. The World Endoscopy Organization methodology was used to perform the RCA and calculate the PCCRC-3y rate. RESULTS: We identified 132 PCCRCs among 52,167 FIT-positive individuals. The PCCRC-3y rate was 6.4% (95% confidence interval [CI] 5.0%–7.7%). PCCRC locations were proximal colon (43.2%), distal colon (34.8%), and rectum (22%). Root causes were likely new CRC (17.4%), missed lesions with adequate (31.2%) or inadequate (9.8%) examination, incomplete polyp resection (22%), and detected but unresected lesions (19.7%). 16.7% of patients with PCCRC had poor bowel preparation on index colonoscopy. The cecal intubation rate was 88.6%, and rectal retroflexion rate was 84.5%. In 14.4% of cases, recommended surveillance intervals did not adhere to established guidelines. Independent predictors of PCCRC were ages 70–79 years (hazard ratio [HR] 7.86; 95% CI 1.08–57.39), age ≥80 years (HR 10.18; 95% CI 1.06–97.98), tubulovillous adenoma (HR 3.98; 95% CI 2.52–6.29), and adenoma with high-grade dysplasia (HR 10.15; 95% CI 5.91–17.42). DISCUSSION: Among FIT-positive individuals, the PCCRC-3y rate was 6.4%, with missed lesions and incomplete resection as key contributors. These findings provide useful information on quality metrics in FIT-based CRC-screening programs.
- Open Access
- 27 May 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e91
Clinical decision support menu for reducing unnecessary urine cultures
A clinical decision support menu requiring selection of urine culture (UC) indication within outpatient and inpatient settings of a large integrated health care system significantly reduced UC sample collection. Clear documentation of selected UC indication in most post-intervention cases affirms its potential as an effective diagnostic stewardship strategy.
- 27 May 2024
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e91
Open AccessClinical decision support menu for reducing unnecessary urine cultures
A clinical decision support menu requiring selection of urine culture (UC) indication within outpatient and inpatient settings of a large integrated health care system significantly reduced UC sample collection. Clear documentation of selected UC indication in most post-intervention cases affirms its potential as an effective diagnostic stewardship strategy.
- Open Access
- 1 February 2023
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 3 (1) , e61
Decreased antimicrobial prescribing rate following academic detailing of resident physicians in outpatient clinic
Among 37 internal-medicine resident physicians assigned to our outpatient clinic at Minneapolis Veterans’ Affairs Health Care System (MVAHCS) on July 1, 2017, we designed a pre- and postintervention observational study. Our results show that in-person academic detailing around outpatient antimicrobial selection was associated with a decrease in outpatient antimicrobial prescriptions in a group of high-prescribing resident physicians.
- 1 February 2023
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 3 (1) , e61
Open AccessDecreased antimicrobial prescribing rate following academic detailing of resident physicians in outpatient clinic
Among 37 internal-medicine resident physicians assigned to our outpatient clinic at Minneapolis Veterans’ Affairs Health Care System (MVAHCS) on July 1, 2017, we designed a pre- and postintervention observational study. Our results show that in-person academic detailing around outpatient antimicrobial selection was associated with a decrease in outpatient antimicrobial prescriptions in a group of high-prescribing resident physicians.
- 9 March 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (5) , 1112-1121
Impact of Antihypertensive Drug Class on Outcomes in SPRINT
Background: The primary objective of this analysis is to assess if greater exposure to any major antihypertensive drug class was associated with reduced primary composite outcome events in SPRINT (Systolic Blood Pressure Intervention Trial). Methods: This is a secondary analysis of the SPRINT trial evaluating whether longitudinal, time varying exposure to any major antihypertensive drug class had any impact on primary outcome events, after adjusting for effects of randomization arm, time varying achieved systolic blood pressure, other drug class exposure, and baseline characteristics. Results: Nine thousand two hundred fifty-two participants were included. After adjustments, exposure of one year or greater to thiazide-type diuretics or renin-angiotensin system blockers was associated with significantly fewer primary events than exposure of less than one year (hazard ratio, 0.78 [95% CI, 0.64–0.94]). There was no significant difference with longer versus shorter exposure to calcium channel blockers. Greater exposure to beta-blockers was associated with an increase in primary events compared with exposure of <1 year (hazard ratio, 1.35 [95% CI, 1.13–1.62]). Furthermore, thiazide-type diuretics were associated with a reduction in heart failure events and renin-angiotensin system blockers with reduced myocardial infarction. Both were associated with less cardiovascular deaths. Conclusions: The SPRINT trial demonstrated a lower target blood pressure led to reductions in adverse cardiovascular events. This analysis suggests greater exposure to thiazide-type diuretics and renin-angiotensin system blockers also contributed to reduced adverse cardiovascular events. Greater exposure to beta-blockers was associated with increased cardiovascular events.
- 9 March 2022
- Published by Wolters Kluwer Health in Hypertension
- Vol. 79 (5) , 1112-1121
Impact of Antihypertensive Drug Class on Outcomes in SPRINT
Background: The primary objective of this analysis is to assess if greater exposure to any major antihypertensive drug class was associated with reduced primary composite outcome events in SPRINT (Systolic Blood Pressure Intervention Trial). Methods: This is a secondary analysis of the SPRINT trial evaluating whether longitudinal, time varying exposure to any major antihypertensive drug class had any impact on primary outcome events, after adjusting for effects of randomization arm, time varying achieved systolic blood pressure, other drug class exposure, and baseline characteristics. Results: Nine thousand two hundred fifty-two participants were included. After adjustments, exposure of one year or greater to thiazide-type diuretics or renin-angiotensin system blockers was associated with significantly fewer primary events than exposure of less than one year (hazard ratio, 0.78 [95% CI, 0.64–0.94]). There was no significant difference with longer versus shorter exposure to calcium channel blockers. Greater exposure to beta-blockers was associated with an increase in primary events compared with exposure of <1 year (hazard ratio, 1.35 [95% CI, 1.13–1.62]). Furthermore, thiazide-type diuretics were associated with a reduction in heart failure events and renin-angiotensin system blockers with reduced myocardial infarction. Both were associated with less cardiovascular deaths. Conclusions: The SPRINT trial demonstrated a lower target blood pressure led to reductions in adverse cardiovascular events. This analysis suggests greater exposure to thiazide-type diuretics and renin-angiotensin system blockers also contributed to reduced adverse cardiovascular events. Greater exposure to beta-blockers was associated with increased cardiovascular events.
- 1 February 2020
- Published by Elsevier in American Journal of Infection Control
- Vol. 48 (2) , 173-177
Risk of surgical site infection after carpal tunnel release performed in an operating room versus a clinic-based procedure room within a Veterans Affairs medical center
- 1 February 2020
- Published by Elsevier in American Journal of Infection Control
- Vol. 48 (2) , 173-177
Risk of surgical site infection after carpal tunnel release performed in an operating room versus a clinic-based procedure room within a Veterans Affairs medical center
- 1 May 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 54 (5) , 620-629
Proactive Tobacco Treatment for Smokers Using Veterans Administration Mental Health Clinics
- 1 May 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 54 (5) , 620-629
Proactive Tobacco Treatment for Smokers Using Veterans Administration Mental Health Clinics
- 1 November 2017
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 62, 130-139
Design, recruitment outcomes, and sample characteristics of the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial
- 1 November 2017
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 62, 130-139
Design, recruitment outcomes, and sample characteristics of the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial